The end of October marks the end of an era, when the Italian Guido Rasi steps down as the Executive Director of the European Medicines Agency (EMA) after ten years in this role.

However, his departure should not be lamented: on the one hand, this is a natural development, since Rasi has been in this role for the maximal amount of years – ten – and on the other hand, and more importantly, Rasi's management style has not been notably progressive, innovative or modern.